Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33 Colorectal Neoplasms 12 Neoplasms 11 Pain, Postoperative 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Head and Neck Neoplasms 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neurotoxicity Syndromes 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Multiple Endocrine Neoplasia Type 1 3

Interventions

Interleukin-7 2 efineptakin alfa 1 angiotensin I (1-7) 1 Transplantation 1 Thymalfasin 1 Sodium Chloride 1 SARS-CoV-2 inactivated vaccines 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Injections 1 Fingolimod Hydrochloride 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphopenia × Sodium Chloride × Clear all

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated

COVID-19, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡